Apontis Pharma AG (ETR:APPH)
Germany · Delayed Price · Currency is EUR 10.85
+0.05 (0.46%)
Aug 1, 2025, 5:36 PM CET
Apontis Pharma AG Employees
Apontis Pharma AG had 137 employees as of December 31, 2024. The number of employees decreased by 40 or -22.60% compared to the previous year.
Employees
137
Change (1Y)
-40
Growth (1Y)
-22.60%
Revenue / Employee
€353,777
Profits / Employee
€5,501
Market Cap
90.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 137 | -40 | -22.60% |
| Dec 31, 2023 | 177 | 2 | 1.14% |
| Dec 31, 2022 | 175 | 7 | 4.17% |
| Dec 31, 2021 | 168 | -22 | -11.58% |
| Dec 31, 2020 | 190 | -10 | -5.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
Apontis Pharma AG News
- 7 weeks ago - EQS-Adhoc: APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40 - Wallstreet:Online
- 4 months ago - APONTIS PHARMA: Big 2024 Gains & Merger Plans Ahead! - Wallstreet:Online
- 4 months ago - EQS-News: APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned - Wallstreet:Online
- 5 months ago - EQS-Adhoc: APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the minority shareholders of APONTIS PHARMA AG – merger agreement planned - Wallstreet:Online
- 8 months ago - EQS-DD: APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane Milz (person closely associated with a person discharging managerial responsibilities). - Wallstreet:Online
- 8 months ago - EQS-DD: APONTIS PHARMA AG: Karin Wohlschlegel, sell - Wallstreet:Online
- 8 months ago - EQS-DD: APONTIS PHARMA AG: be executive GmbH, sell - Wallstreet:Online
- 8 months ago - EQS-DD: APONTIS PHARMA AG: Thomas Zimmermann, sell - Wallstreet:Online